NCT02325739
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02325739
Title Safety and Efficacy of FGF401 in Patients With Solid Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU

Facility Status City State Zip Country Details
University of California LA Santa Monica Location Los Angeles California 90095 United States Details
Massachusetts General Hospital Oncology Dept Boston Massachusetts 02114 United States Details
Uni Of TX MD Anderson Cancer Cntr Houston Texas 77030 United States Details
Novartis Investigative Site Shanghai Shanghai Municipality 200032 China Details
Novartis Investigative Site Rennes Ille Et Vilaine 35062 France Details
Novartis Investigative Site Lille 59037 France Details
Novartis Investigative Site Montpellier 34295 France Details
Novartis Investigative Site Pessac 33604 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Hanover 30625 Germany Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Würzburg 97080 Germany Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Milan MI 20132 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Ōsaka-sayama Osaka 589 8511 Japan Details
Novartis Investigative Site Chuo Ku Tokyo 104 0045 Japan Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Seoul 03080 South Korea Details
Novartis Investigative Site Seoul 05505 South Korea Details
Novartis Investigative Site Seoul 06351 South Korea Details
Novartis Investigative Site Barcelona Catalonia 08035 Spain Details
Novartis Investigative Site Barcelona Catalonia 08036 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Tainan 70403 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field